CD274 and nonpapillary renal cell carcinoma: In cases of ccRCC with sarcomatoid and rhabdoid differentiation—tumors known for their high aggressiveness—the combination of ICIs has shown potential for improved responses and outcomes, likely due to immune‐inflamed phenotype and elevated PD‐1 and PD‐L1 expression [26, 27].